抗炎症治療剤の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Anti-inflammatory Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-01600 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、抗炎症治療剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗炎症治療剤の種類別市場規模（抗炎症性生物製剤、NSAID、コルチコステロイド）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Pfizer、Amgen、Novartis、Johnson & Johnson、Eli Lilly、Boehringer Ingelheim ・地域別グローバル市場分析 2015年-2020年 ・抗炎症治療剤の北米市場（アメリカ、カナダ、メキシコ） ・抗炎症治療剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗炎症治療剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗炎症治療剤の南米市場（ブラジル、アルゼンチン） ・抗炎症治療剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗炎症性生物製剤、NSAID、コルチコステロイド ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Anti-inflammatory Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 81620 million by 2025, from USD 63230 million in 2019.

The Anti-inflammatory Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anti-inflammatory Therapeutics market has been segmented into:
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids

By Application, Anti-inflammatory Therapeutics has been segmented into:
Hospitals
Clinics

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-inflammatory Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-inflammatory Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-inflammatory Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Anti-inflammatory Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Anti-inflammatory Therapeutics Market Share Analysis
Anti-inflammatory Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-inflammatory Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-inflammatory Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Anti-inflammatory Therapeutics are:
AbbVie
Pfizer
Amgen
Novartis
Johnson & Johnson
Eli Lilly
Boehringer Ingelheim

レポート目次

---

Table of Contents

1 Anti-inflammatory Therapeutics Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Therapeutics
1.2 Classification of Anti-inflammatory Therapeutics by Type
1.2.1 Global Anti-inflammatory Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2019
1.2.3 Anti-Inflammatory Biologicals
1.2.4 NSAIDs
1.2.5 Corticosteroids
1.3 Global Anti-inflammatory Therapeutics Market by Application
1.3.1 Overview: Global Anti-inflammatory Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anti-inflammatory Therapeutics Market by Regions
1.4.1 Global Anti-inflammatory Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anti-inflammatory Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anti-inflammatory Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-inflammatory Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-inflammatory Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anti-inflammatory Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-inflammatory Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Boehringer Ingelheim SWOT Analysis
2.7.4 Boehringer Ingelheim Product and Services
2.7.5 Boehringer Ingelheim Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-inflammatory Therapeutics Players Market Share
3.2.2 Top 10 Anti-inflammatory Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Regions
4.2 North America Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Anti-inflammatory Therapeutics Revenue by Countries
5.1 North America Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
5.2 USA Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Anti-inflammatory Therapeutics Revenue by Countries
6.1 Europe Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Countries
7.1 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
7.2 China Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Anti-inflammatory Therapeutics Revenue by Countries
8.1 South America Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anti-inflammatory Therapeutics by Countries
9.1 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2019-2024)
10.3 Anti-Inflammatory Biologicals Revenue Growth Rate (2015-2025)
10.4 NSAIDs Revenue Growth Rate (2015-2025)
10.5 Corticosteroids Revenue Growth Rate (2015-2025)
11 Global Anti-inflammatory Therapeutics Market Segment by Application
11.1 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Anti-inflammatory Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
12 Global Anti-inflammatory Therapeutics Market Size Forecast (2021-2025)
12.1 Global Anti-inflammatory Therapeutics Market Size Forecast (2021-2025)
12.2 Global Anti-inflammatory Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anti-inflammatory Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie Anti-inflammatory Therapeutics Major Business
Table 7. AbbVie Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie Anti-inflammatory Therapeutics Product and Solutions
Table 10. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Anti-inflammatory Therapeutics Major Business
Table 13. Pfizer Anti-inflammatory Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Anti-inflammatory Therapeutics Product and Solutions
Table 16. Pfizer Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen Anti-inflammatory Therapeutics Major Business
Table 19. Amgen Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen Anti-inflammatory Therapeutics Product and Solutions
Table 22. Amgen Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Anti-inflammatory Therapeutics Major Business
Table 25. Novartis Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Anti-inflammatory Therapeutics Product and Solutions
Table 28. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson & Johnson Corporate Information, Location and Competitors
Table 30. Johnson & Johnson Anti-inflammatory Therapeutics Major Business
Table 31. Johnson & Johnson Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Johnson & Johnson SWOT Analysis
Table 33. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
Table 34. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly Corporate Information, Location and Competitors
Table 36. Eli Lilly Anti-inflammatory Therapeutics Major Business
Table 37. Eli Lilly Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Anti-inflammatory Therapeutics Product and Solutions
Table 40. Eli Lilly Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 42. Boehringer Ingelheim Anti-inflammatory Therapeutics Major Business
Table 43. Boehringer Ingelheim Anti-inflammatory Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Boehringer Ingelheim SWOT Analysis
Table 45. Boehringer Ingelheim Anti-inflammatory Therapeutics Product and Solutions
Table 46. Boehringer Ingelheim Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Anti-inflammatory Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 48. Global Anti-inflammatory Therapeutics Revenue Share by Players (2015-2020)
Table 49. Global Anti-inflammatory Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Anti-inflammatory Therapeutics Revenue Market Share by Regions (2015-2020)
Table 51. North America Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
Table 52. North America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Table 53. Europe Anti-inflammatory Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Anti-inflammatory Therapeutics Revenue by Countries (2015-2020)
Table 56. South America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Anti-inflammatory Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Global Anti-inflammatory Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 60. Global Anti-inflammatory Therapeutics Revenue Share by Type (2015-2020)
Table 61. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2021-2025)
Table 62. Global Anti-inflammatory Therapeutics Revenue by Application (2015-2020)
Table 63. Global Anti-inflammatory Therapeutics Revenue Share by Application (2015-2020)
Table 64. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2021-2025)
Table 65. Global Anti-inflammatory Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2019
Figure 3. Anti-Inflammatory Biologicals Picture
Figure 4. NSAIDs Picture
Figure 5. Corticosteroids Picture
Figure 6. Anti-inflammatory Therapeutics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Global Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Anti-inflammatory Therapeutics Revenue Market Share in 2019
Figure 18. Global Top 10 Players Anti-inflammatory Therapeutics Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 22. Global Anti-inflammatory Therapeutics Revenue Market Share by Regions in 2018
Figure 23. North America Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 24. Europe Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. South America Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. North America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 29. North America Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2019
Figure 30. USA Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Canada Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2019
Figure 35. Germany Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. UK Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. France Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Russia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Italy Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2019
Figure 42. China Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Japan Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Korea Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. India Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. South America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. South America Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2019
Figure 49. Brazil Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. UAE Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Anti-inflammatory Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Global Anti-inflammatory Therapeutics Revenue Share by Type (2015-2020)
Figure 58. Global Anti-inflammatory Therapeutics Revenue Share by Type in 2019
Figure 59. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2021-2025)
Figure 60. Global Anti-Inflammatory Biologicals Revenue Growth Rate (2015-2020)
Figure 61. Global NSAIDs Revenue Growth Rate (2015-2020)
Figure 62. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 63. Global Anti-inflammatory Therapeutics Revenue Share by Application (2015-2020)
Figure 64. Global Anti-inflammatory Therapeutics Revenue Share by Application in 2019
Figure 65. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-inflammatory Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Anti-inflammatory Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
Figure 72. Europe Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. South America Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---